Young K A, Munroe M E, Harley J B, Guthridge J M, Kamen D L, Gilkensen G S, Weisman M H, Karp D R, Wallace D J, James J A, Norris J M
1 Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, USA.
2 Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Lupus. 2018 Aug;27(9):1524-1531. doi: 10.1177/0961203318778368. Epub 2018 May 28.
Background The role of sleep in the etiology of systemic lupus erythematosus (SLE) has not been well studied. We examined whether sleep duration was associated with subsequent transitioning to SLE in individuals at risk for SLE. Methods Four hundred and thirty-six relatives of SLE patients who did not have SLE themselves at baseline were evaluated again an average of 6.3 (± 3.9) years later. Fifty-six individuals transitioned to SLE (≥ 4 cumulative American College of Rheumatology (ACR) criteria). Sleep duration, medication use and medical history were assessed by questionnaire; ACR criteria were confirmed by medical record review. Vitamin D was measured by ELISA. Generalized estimating equations, accounting for correlation within families, assessed associations between baseline sleep and the outcome of transitioning to SLE. Results Reporting sleeping less than 7 hours per night at baseline was more common in those who subsequently transitioned than those who did not transition to SLE (55% versus 32%, p = 0.0005; OR: 2.8, 95% CI 1.6-4.9). Those who transitioned to SLE were more likely to sleep less than 7 hours per night than those who did not transition to SLE adjusting for age, sex and race (OR: 2.8, 95% CI 1.6-5.1). This association remained after individual adjustment for conditions and early symptoms that could affect sleep, including prednisone use, vitamin D deficiency and number of ACR criteria (OR: 2.0, 95% CI 1.1-4.2). Conclusion Lack of sleep may be associated with transitioning to SLE, independent of early clinical manifestations of SLE that may influence sleep duration. Further evaluation of sleeping patterns and biomarkers in at-risk individuals is warranted.
睡眠在系统性红斑狼疮(SLE)病因学中的作用尚未得到充分研究。我们研究了睡眠时间是否与有SLE风险的个体随后发展为SLE有关。方法:对436名基线时未患SLE的SLE患者亲属平均在6.3(±3.9)年后再次进行评估。56人发展为SLE(累积美国风湿病学会(ACR)标准≥4项)。通过问卷调查评估睡眠时间、用药情况和病史;通过病历审查确认ACR标准。采用酶联免疫吸附测定法(ELISA)检测维生素D。广义估计方程考虑了家庭内部的相关性,评估基线睡眠与发展为SLE结局之间的关联。结果:在随后发展为SLE的人群中,报告基线时每晚睡眠时间少于7小时的情况比未发展为SLE的人群更为常见(55%对32%,p = 0.0005;OR:2.8,95%CI 1.6 - 4.9)。在调整年龄、性别和种族后,发展为SLE的人比未发展为SLE的人更有可能每晚睡眠时间少于7小时(OR:2.8,95%CI 1.6 - 5.1)。在对可能影响睡眠的疾病和早期症状进行个体调整后,这种关联仍然存在,包括泼尼松使用、维生素D缺乏和ACR标准数量(OR:2.0,95%CI 1.1 - 4.2)。结论:睡眠不足可能与发展为SLE有关,独立于可能影响睡眠时间的SLE早期临床表现。有必要对高危个体的睡眠模式和生物标志物进行进一步评估。